3D QSAR studies on a series of potent and high selective inhibitors for three kinases of RTK family

被引:28
作者
Cao, Hongyu
Zhang, Huabei [1 ]
Zheng, Xuefang
Gao, Dabin
机构
[1] Beijing Normal Univ, Coll Chem, Key Lab Radiopharmaceut, Minist Educ, Beijing 100875, Peoples R China
[2] Dalian Univ, Liaoning Key Lab Bioorgan Chem, Dalian 116622, Peoples R China
基金
中国国家自然科学基金;
关键词
KDR; cKit; tie-2; CoMFA; CoMSIA; selective inhibitor;
D O I
10.1016/j.jmgm.2006.12.001
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
For targets belonging to the same family of receptors, inhibitors often act at more than one biological target and produce a synergistic effect. Separate CoMFA and CoMSIA models were developed from our data set for the KDR, cKit and Tie-2 inhibitors. These models showed excellent internal predictability and consistency, and validation using test-set compounds yielded a good predictive power for the pIC(50) value. The field contour maps (CoMFA and CoMSIA) corresponding to the KDR, cKit and Tie-2 kinase subtypes reflected the characteristic similarities and differences between these types. These maps provided valuable information to facilitate structural modifications of the inhibitor to increase selectivity for the KDR over cKit and Tie-2. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:236 / 245
页数:10
相关论文
共 30 条
[1]   Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate [J].
Adamis, AP ;
Shima, DT ;
Tolentino, MJ ;
Gragoudas, ES ;
Ferrara, N ;
Folkman, J ;
DAmore, PA ;
Miller, JW .
ARCHIVES OF OPHTHALMOLOGY, 1996, 114 (01) :66-71
[2]  
[Anonymous], 2004, SYBYL 7 0 MAN
[3]   Selectivity fields: Comparative molecular field analysis (CoMFA) of the glycine/NMDA and AMPA receptors [J].
Baskin, II ;
Tikhonova, IG ;
Palyulin, VA ;
Zefirov, NS .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (19) :4063-4069
[4]   Kinase insert domain-containing receptor kinase inhibitors as anti-angiogenic agents [J].
Bilodeau, MT ;
Fraley, ME ;
Hartman, GD .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2002, 11 (06) :737-745
[5]  
Borgstrom P, 1996, CANCER RES, V56, P4032
[6]   Angiogenesis in cancer and other diseases [J].
Carmeliet, P ;
Jain, RK .
NATURE, 2000, 407 (6801) :249-257
[7]   COMPARATIVE MOLECULAR-FIELD ANALYSIS (COMFA) .1. EFFECT OF SHAPE ON BINDING OF STEROIDS TO CARRIER PROTEINS [J].
CRAMER, RD ;
PATTERSON, DE ;
BUNCE, JD .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1988, 110 (18) :5959-5967
[8]   Thienopyrimidine ureas as novel and potent multitargeted receptor tyrosine kinase inhibitors [J].
Dai, YJ ;
Guo, Y ;
Frey, RR ;
Ji, ZQ ;
Curtin, ML ;
Ahmed, AA ;
Albert, DH ;
Arnold, L ;
Arries, SS ;
Barlozzari, T ;
Bauch, JL ;
Bouska, JJ ;
Bousquet, PF ;
Cunha, GA ;
Glaser, KB ;
Guo, J ;
Li, JL ;
Marcotte, PA ;
Marsh, KC ;
Moskey, MD ;
Pease, LJ ;
Stewart, KD ;
Stoll, VS ;
Tapang, P ;
Wishart, N ;
Davidsen, SK ;
Michaelides, MR .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (19) :6066-6083
[9]   THE FMS-LIKE TYROSINE KINASE, A RECEPTOR FOR VASCULAR ENDOTHELIAL GROWTH-FACTOR [J].
DEVRIES, C ;
ESCOBEDO, JA ;
UENO, H ;
HOUCK, K ;
FERRARA, N ;
WILLIAMS, LT .
SCIENCE, 1992, 255 (5047) :989-991
[10]   Differential roles of vascular endothelial growth factor receptors 1 and 2 in dendritic cell differentiation [J].
Dikov, MM ;
Ohm, JE ;
Ray, N ;
Tchekneva, EE ;
Burlison, J ;
Moghanaki, D ;
Nadaf, S ;
Carbone, DP .
JOURNAL OF IMMUNOLOGY, 2005, 174 (01) :215-222